Abas Sezer

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Epithelial Mesenchymal Transition

Diffuse Large B Cell Lymphoma

Protein Protein

Molecular Docking

Top Venues

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Abas Sezer, Lejla Mahmutović, Betul Akcesme
In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma. Medical oncology (Northwood, London, England) 41 (1) (2023)
Abas Sezer, Lejla Mahmutović, Betul Akcesme
In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma. Medical oncology (Northwood, London, England) 41 (1) (2023)
Abas Sezer, Lejla Mahmutović, Betul Akcesme
In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma. Medical oncology (Northwood, London, England) 41 (1) (2023)
Abas Sezer, Lejla Mahmutović, Betul Akcesme
In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma. Medical oncology (Northwood, London, England) 41 (1) (2023)
Altijana Hromić-Jahjefendić, Abas Sezer, Alaa A A Aljabali, Ãngel Serrano-Aroca, Murtaza M Tambuwala, Vladimir N Uversky, Elrashdy Mustafa Redwan, Debmalya Barh, Kenneth Lundstrom
COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence. Biomedicines 11 (5) (2023)